Calicum, MARCKS, and PIP2 regulation of ENaC

ENaC 的钙、MARCKS 和 PIP2 调节

基本信息

  • 批准号:
    8700958
  • 负责人:
  • 金额:
    $ 13.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-06-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

Abstract Hypertension is a major public health concern because it is an important risk factor for many other diseases including congestive heart failure, stroke, and end-stage renal disease. The constitutive activation of epithelial sodium channels (ENaC) leads to severe hypertension, while subtle stimulation of ENaC may contribute to essential hypertension. Therefore, understanding the regulation of ENaC is important to understand the etiology of hypertension. Our laboratory was among the first to show that ENaC activity requires binding of phosphatidylinositol bis-phosphate (PIP2) to the amino terminal domain of ENaC subunits. We used a tissue culture model of distal nephron sodium transport and we showed that the PIP2 dependent regulation of ENaC is mediated by an adaptor protein, myristoylated alanine-rich C kinase substrate (MARCKS), that binds PIP2 and increases the local concentration of PIP2 near ENaC and, thereby, activates ENaC. The myristoylated amino terminal domain and the basic effector domain of MARCKS both contribute to its function at the apical plasma membrane. The function of MARCKS can be regulated by posttranslational modifications, association with calcium/calmodulin, and proteolysis so that regulation of MARCKS is also important for regulating ENaC. The aims of this project are to show how MARCKS regulates ENaC in vivo and identify the molecular mechanisms that regulate MARCKS activity at the apical membrane of renal epithelial cells.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Abdel Ayube Alli其他文献

Abdel Ayube Alli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Abdel Ayube Alli', 18)}}的其他基金

The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
肾脏中生物钟蛋白 BMAL 和 ENaC 的翻译后调节
  • 批准号:
    10202590
  • 财政年份:
    2020
  • 资助金额:
    $ 13.37万
  • 项目类别:
The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
肾脏中生物钟蛋白 BMAL 和 ENaC 的翻译后调节
  • 批准号:
    10662317
  • 财政年份:
    2020
  • 资助金额:
    $ 13.37万
  • 项目类别:
The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
肾脏中生物钟蛋白 BMAL 和 ENaC 的翻译后调节
  • 批准号:
    10440278
  • 财政年份:
    2020
  • 资助金额:
    $ 13.37万
  • 项目类别:
Calicum, MARCKS, and PIP2 regulation of ENaC
ENaC 的钙、MARCKS 和 PIP2 调节
  • 批准号:
    9283532
  • 财政年份:
    2014
  • 资助金额:
    $ 13.37万
  • 项目类别:
Calicum, MARCKS, and PIP2 regulation of ENaC
ENaC 的钙、MARCKS 和 PIP2 调节
  • 批准号:
    9245699
  • 财政年份:
    2014
  • 资助金额:
    $ 13.37万
  • 项目类别:
Regulation of ENaC by phosphoinositides, MARCKS, and the cytoskeleton
磷酸肌醇、MARCKS 和细胞骨架对 ENaC 的调节
  • 批准号:
    8203348
  • 财政年份:
    2011
  • 资助金额:
    $ 13.37万
  • 项目类别:
Regulation of ENaC by phosphoinositides, MARCKS, and the cytoskeleton
磷酸肌醇、MARCKS 和细胞骨架对 ENaC 的调节
  • 批准号:
    8389828
  • 财政年份:
    2011
  • 资助金额:
    $ 13.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了